B. Riedl

发表

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

D. Auclair, P. Vincent, G. Bollag, 2004, Cancer Research.

Potent Inhibition of HIF1α and p300 Interaction by a Constrained Peptide Derived from CITED2.

Feng Yin, Zigang Li, D. Bierer, 2021, Journal of medicinal chemistry.

Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling

S. Pullamsetti, R. Savai, H. Ghofrani, 2008, Circulation.

Selective neuropeptide Y conjugates with maximized carborane loading as promising boron delivery agents for boron neutron capture therapy.

E. Hey‐Hawkins, A. Beck‐Sickinger, B. Riedl, 2019, Journal of medicinal chemistry.

Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability.

A. Beck‐Sickinger, B. Riedl, Sylvia Els-Heindl, 2016, Journal of medicinal chemistry.

Enlargement of a Modular System—Synthesis and Characterization of an s-Triazine-Based Carboxylic Acid Ester Bearing a Galactopyranosyl Moiety and an Enormous Boron Load

E. Hey‐Hawkins, P. Lönnecke, B. Riedl, 2019, Molecules.

Tuning a modular system - synthesis and characterisation of a boron-rich s-triazine-based carboxylic acid and amine bearing a galactopyranosyl moiety.

E. Hey‐Hawkins, A. Beck‐Sickinger, P. Lönnecke, 2019, Dalton transactions.

Modular triazine-based carborane-containing carboxylic acids - synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks.

E. Hey‐Hawkins, A. Beck‐Sickinger, P. Lönnecke, 2019, Dalton transactions.

A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.

E. Hey‐Hawkins, A. Beck‐Sickinger, B. Riedl, 2019, The Journal of organic chemistry.

A stable meta‐carborane enables the generation of boron‐rich peptide agonists targeting the ghrelin receptor

E. Hey‐Hawkins, A. Beck‐Sickinger, B. Riedl, 2018, Journal of peptide science : an official publication of the European Peptide Society.

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituent.

Xiao-Gao Liu, Barbara Hibner, Joel Renick, 2004, Bioorganic & medicinal chemistry letters.

Receptor Tyrosine Kinases Involved in Tumor Progression Activity and Targets the RAF/MEK/ERK Pathway and BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor

D. Auclair, P. Vincent, G. Bollag, 2004 .

A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of Cancer

B. Riedl, J. Dumas, R. Sibley, 2002 .

Synthesis of bromodifluoromethyl(arylsulfonyl) compounds and microwave-assisted nickel catalyzed cross coupling with arylboronic acids

D. Bierer, B. Riedl, R. Baker, 2016 .

Fluorescently labeled adrenomedullin allows real‐time monitoring of adrenomedullin receptor trafficking in living cells

C. Holze, A. Beck‐Sickinger, B. Riedl, 2015, Journal of peptide science : an official publication of the European Peptide Society.

1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.

J. S. Johnson, T. Turner, S. Wilhelm, 2000, Bioorganic & medicinal chemistry letters.

The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor‐like Receptor/Receptor Activity‐Modifying Protein System

D. Bierer, A. Beck‐Sickinger, B. Riedl, 2018, ChemMedChem.

Adrenomedullin disulfide bond mimetics uncover structural requirements for AM1 receptor activation

D. Bierer, A. Beck‐Sickinger, B. Riedl, 2019, Journal of peptide science : an official publication of the European Peptide Society.

Synthesis of Enantiomerically Pure and Compatibly Protected (2S,3R)- and (2S,3S)-Diaminobutyric Acids

U. Schmidt, B. Riedl, Gerhard Haas, 1993 .

Diastereoselective Formation of (Z)-Didehydroamino Acid Esters

U. Schmidt, B. Riedl, H. Griesser, 1992 .

The total synthesis of antrimycin Dv

U. Schmidt, B. Riedl, 1992 .

A Useful Synthesis of (R,R)-1,2-Ethanediylbis[(o-methoxyphenyl)phenylphosphine] the Ligand of the Enantioselective Catalyst [Rh(COD) (DIPAMP)]+ BF4-

U. Schmidt, B. Riedl, H. Griesser, 1991 .

Recent developments with oxazolidinone antibiotics

B. Riedl, R. Endermann, 1999 .

1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.

J. S. Johnson, T. Turner, S. Wilhelm, 2000, Bioorganic & medicinal chemistry letters.

Contribution to the synthesis of aureobasidin A. Synthesis of cyclopeptolides containing the sequence leucyl-N-methyl-beta-hydroxyvalyl-(2R)-oxy-(3R)-methyl-pentanoi c acid.

U. Schmidt, B. Riedl, J. Mittendorf, 2009, The journal of peptide research : official journal of the American Peptide Society.

The Total Synthesis of Antrimycin Dv; II: Synthesis of Tetrahydropyridazinecarboxylic Acid and Its Incorporation into Peptides

U. Schmidt, B. Riedl, 1993 .

Enantioselective and diastereoselective formation of syn-3-hydroxy-4-amino acids (syn-statines) via tetramic acids

U. Schmidt, B. Riedl, H. Griesser, 1993 .

Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.

B. Riedl, T. Marquardt, H. Zimmermann, 2012, Antiviral research.

Non-reducible disulfide bond replacement implies that disulfide exchange is not required for hepcidin-ferroportin interaction.

Xia Wang, D. Bierer, E. Pook, 2019, Chemical communications.

Discovery of a new class of p38 kinase inhibitors.

J. S. Johnson, S. Wilhelm, W. Scott, 2000, Bioorganic & medicinal chemistry letters.

The Novel α7 Nicotinic Acetylcholine Receptor Agonist N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide Improves Working and Recognition Memory in Rodents

J. Vry, F. J. van der Staay, B. Riedl, 2007, Journal of Pharmacology and Experimental Therapeutics.

Chimeric protein probes for C5a receptors through fusion of the anaphylatoxin C5a core region with a small-molecule antagonist

Lei Liu, D. Bierer, E. Pook, 2019, Science China Chemistry.

Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential

A. Beck‐Sickinger, B. Riedl, Sylvia Els-Heindl, 2016, ChemMedChem.

126 Combined inhibition of tyrosine‐ and serine‐/threonine kinases in pulmonary hypertension: Sorafenib prevents vascular and myocardial remodeling

F. Grimminger, R. Schermuly, B. Riedl, 2007 .

Design and discovery of small molecules targeting raf-1 kinase.

B. Riedl, Jacques Dumas, J. Dumas, 2002, Current pharmaceutical design.

Pinpointing the interaction site between semaphorin‐3A and its inhibitory peptide

A. Beck‐Sickinger, B. Riedl, K. Bellmann-Sickert, 2022, Journal of peptide science : an official publication of the European Peptide Society.

Rational design of highly stabilized and selective adrenomedullin analogs.

A. Beck‐Sickinger, B. Riedl, I. Flamme, 2023, Journal of peptide science : an official publication of the European Peptide Society.

The Novel (cid:1) 7 Nicotinic Acetylcholine Receptor Agonist N -[(3 R Improves Working and Recognition Memory in Rodents

J. Vry, B. Riedl, F. Boess, 2007 .

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

D. Auclair, P. Vincent, G. Bollag, 2004, Cancer Research.

Straightforward syntheses of furanomycin derivatives and their biological evaluation.

B. Riedl, H. Kroll, R. Endermann, 2002, Bioorganic & Medicinal Chemistry.